Department of Electrophysiology, German Heart Center Munich, Technical University of Munich, Lazarettstraße 36, 80636, Munich, Germany.
Department of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Sci Rep. 2024 Oct 25;14(1):25370. doi: 10.1038/s41598-024-76098-2.
The question of optimal timing for catheter ablation of atrial fibrillation (AF) to achieve best outcomes remains a crucial clinical issue. As AF occurs less frequently in younger patients, data regarding Diagnosis-to-Ablation Time (DAT) is especially limited in patients under the age of 55 years with persistent AF. We therefore analyzed the temporal relationship between initial AF presentation and timing of catheter ablation in this cohort. We conducted a retrospective single-centre study of patients ≤ 55 years with persistent AF who underwent first-time catheter ablation at our center. The cohort was divided into patients that underwent catheter ablation after diagnosis of persistent AF within a DAT of ≤ 12 months and patients with a DAT of > 12 months. A total of 101 patients (median age 51 years; female n = 19 (18.8%)) with persistent AF were included. Ablation was performed within 12 months ("early DAT") in 51 patients and > 12 months ("late DAT") in 50 patients. Pulmonary vein isolation was performed using high-power short-duration (HPSD) radiofrequency ablation. Median DAT was 5 months (1-12 months) in the early ablation group and 36 months (13-240 months) in the late ablation group. The median follow-up was 11.3 months (0.03-37.1 months). The rate of any atrial arrhythmia recurrence after a 30-day blanking period was significantly lower in the early DAT group (13/51 patients; 25.5%) as compared to the late DAT group (26/50 patients; 52.0%) (log rank test; p = 0.003). Catheter ablation performed > 12 months after the initial AF diagnosis was an independent predictor for the occurrence of any atrial arrythmia (OR: 2.58; (95%-CI: 1.32-5.07). Early first-time catheter ablation (DAT ≤ 12 months) in patients ≤ 55 years with persistent AF is associated with a significantly lower rate of arrhythmia recurrence.
房颤(AF)导管消融的最佳时机以实现最佳疗效仍然是一个关键的临床问题。由于年轻患者的房颤发作频率较低,因此年龄在 55 岁以下持续性房颤患者的诊断到消融时间(DAT)数据尤其有限。因此,我们在该队列中分析了初始 AF 发作与导管消融时间之间的时间关系。我们对在我们中心首次接受导管消融治疗的年龄≤55 岁的持续性房颤患者进行了回顾性单中心研究。该队列分为 DAT≤12 个月内行导管消融的患者和 DAT>12 个月的患者。共纳入 101 例持续性房颤患者(中位年龄 51 岁;女性 n=19(18.8%))。51 例患者在 12 个月内(“早期 DAT”)行消融,50 例患者在 12 个月后(“晚期 DAT”)行消融。肺静脉隔离采用高功率短时间(HPSD)射频消融。早期消融组的中位 DAT 为 5 个月(1-12 个月),晚期消融组为 36 个月(13-240 个月)。中位随访时间为 11.3 个月(0.03-37.1 个月)。在 30 天空白期后,任何房性心律失常复发的发生率在早期 DAT 组(51 例患者中有 13 例;25.5%)明显低于晚期 DAT 组(50 例患者中有 26 例;52.0%)(对数秩检验;p=0.003)。与首次 AF 诊断后 12 个月以上进行导管消融相比,任何房性心律失常的发生是独立预测因素(OR:2.58;(95%-CI:1.32-5.07)。年龄≤55 岁的持续性房颤患者首次行早期导管消融(DAT≤12 个月)与心律失常复发率显著降低相关。